METTL3 promotes the degradation of Irakm mRNA by adding m6A modification, enhancing TLR4 signaling, activating macrophages, and inducing M1 polarization in TAMs, thereby increasing their tumor-killing ability (61). Here, METTL3 is linked to neoplasm.